Metropolis
With Metropolis, the top pathology lab in India, we live by the conviction that everything we say and do should be a reflection of what we think, and we make sure that everything we say and do is consistent with these principles. The following are some examples of these tenets: It is ingrained in the culture of our business to show sympathy for our clients and to make it a priority to fulfill their requirements in every way. Openness, collaboration, forward-thinking, and scientific curiosity are all hallmarks of the culture of the city of Metropolis, which is known for its forward thinking.
They are the foremost authorities in the field of pathology, and we deliver more than 30 million diagnostic tests on an annual basis to more than 20,000 hospitals, nursing homes, and consulting offices. The Metropolis pathology lab has established a name for itself as one of the most reputable facilities of its kind in India because it has maintained a record of 37 years of consistently reliable diagnostic output.
The diagnostic and preventative healthcare services provided by Metropolis include, but are not limited to business and wellness solutions, blood testing, clinical trials, hospital lab management, home health services, preventative health check-ups, and more. When it comes to putting into practice forward-thinking medical practices and cutting-edge technologies that are tailored to the specific needs of individual patients, Metropolis is at the forefront of the industry. They also provide different discounts for the various packages they provide; Offer on the Women’s Package by Metropolis Offer on the Basic Package by Metropolis Offer on the Master Package by Metropolis Offer on the Comprehensive Package by Metropolis
They are the foremost authorities in the field of pathology, and we deliver more than 30 million diagnostic tests on an annual basis to more than 20,000 hospitals, nursing homes, and consulting offices. The Metropolis pathology lab has established a name for itself as one of the most reputable facilities of its kind in India because it has maintained a record of 37 years of consistently reliable diagnostic output.
The diagnostic and preventative healthcare services provided by Metropolis include, but are not limited to business and wellness solutions, blood testing, clinical trials, hospital lab management, home health services, preventative health check-ups, and more. When it comes to putting into practice forward-thinking medical practices and cutting-edge technologies that are tailored to the specific needs of individual patients, Metropolis is at the forefront of the industry. They also provide different discounts for the various packages they provide; Offer on the Women’s Package by Metropolis Offer on the Basic Package by Metropolis Offer on the Master Package by Metropolis Offer on the Comprehensive Package by Metropolis
Offers By Metropolis
Offer By Metropolis on Women Package
Offer By Metropolis on Women Package
Offer By Metropolis on Women Package
Diagnosis Center
Department | Test Name | MRP | ||||||||||
Allergy | ACTH * | 1275 | ||||||||||
Clinical Chemistry - General | 17-Hydroxy Progesterone, Serum | 1500 | ||||||||||
Infectious diseases | 2-Tube Assay | 2700 | ||||||||||
Haematology | Abnormal Haemoglobin Studies , EDTA Whole blood | 990 | ||||||||||
Clinical Chemistry - General | ACE-Angiotensin Converting Enzyme, Serum | 1100 | ||||||||||
Clinical pathology | Acetone-qualitative, Urine | 75 | ||||||||||
Clinical Chemistry - General | ACTH Stimulation Test for 17 OH Progesterone, Serum | 3625 | ||||||||||
Clinical Chemistry - General | ACTH Stimulation Test for Cortisol*, Serum | 1750 | ||||||||||
Clinical Chemistry - General | ACTH Stimulation Test for DHEAS, Serum | 2750 | ||||||||||
Clinical Chemistry - General | ACTH-Adreno Corticotropic Hormone*, EDTA Plasma | 1600 | ||||||||||
Clinical Chemistry - General | AFP-Alpha Feto Protein* MoM, Serum | 950 | ||||||||||
Clinical Chemistry - General | AFP-Alpha Feto Protein*, Serum | 900 | ||||||||||
Infectious diseases | Albert's stain, Throat swab | 350 | ||||||||||
Clinical Chemistry - General | Albumin* Serum | 220 | ||||||||||
Clinical Chemistry - General | Albumin*, body fluid | 200 | ||||||||||
Clinical Chemistry - General | Albumin/Creatinine Ratio*, Spot urine | 550 | ||||||||||
Clinical pathology | Albumin-Qualitative, Urine | 75 | ||||||||||
Clinical Chemistry - General | Albumin-quantitative*, Urine 24H | 580 | ||||||||||
Anatomic pathology | Alcian Blue | 1300 | ||||||||||
Anatomic pathology | Alcian Blue Stain | 700 | ||||||||||
Infectious diseases | Aldehyde Chopra Test, Serum | 450 | ||||||||||
Clinical Chemistry - General | Alkaline Phosphatase*, Serum | 220 | ||||||||||
Profiles | Amenorrhoea Profile, Female | 1950 | ||||||||||
Profiles | AMH Premium | 2920 | ||||||||||
Profiles | AMH Supreme | 4300 | ||||||||||
Clinical Chemistry - General | AMH-Anti Mullerian Hormone*, Serum | 2000 | ||||||||||
Clinical Chemistry - General | Amphiphysin Antibody, Serum | 4700 | ||||||||||
Clinical Chemistry - General | Amylase, Ascitic Fluid* | 450 | ||||||||||
Clinical Chemistry - General | Amylase, Pleural fluid * | 525 | ||||||||||
Clinical Chemistry - General | Amylase, Serum* | 475 | ||||||||||
Clinical Chemistry - General | Amylase, Spot urine* | 525 | ||||||||||
Clinical Chemistry - General | Amylase, urine 24 H* | 525 | ||||||||||
Clinical Chemistry - General | ANA by ELISA, Serum | 750 | ||||||||||
Clinical Chemistry - General | ANA by IFA, Serum | 990 | ||||||||||
Clinical Chemistry - General | ANA Profile by EIA, Serum | 5000 | ||||||||||
Clinical Chemistry - General | ANA Profile, 17 antigens by Immunoblot, Serum | 3300 | ||||||||||
Clinical Chemistry - General | ANCA by IFA, Reflex MPO / PR3 Antibodies by EIA, serum | 2500 | ||||||||||
Clinical Chemistry - General | ANCA Profile by IFA, Serum | 1980 | ||||||||||
Profiles | Antenatal (ANC) Profile-I | 2900 | ||||||||||
Profiles | Antenatal (ANC) Profile-II | 1400 | ||||||||||
Infectious diseases | Anti HBcAg total by CMIA, Serum | 1000 | ||||||||||
Infectious diseases | Anti HBeAg, Serum | 1000 | ||||||||||
Infectious diseases | Anti HbsAg antibody, Serum | 1000 | ||||||||||
Anti-SARS -CoV-2-Spike IgG, Quantitative* | 1200 | |||||||||||
Clinical Chemistry - General | APA-IgG, Serum | 1000 | ||||||||||
Clinical Chemistry - General | APA-IgM, Serum | 1000 | ||||||||||
Clinical Chemistry - General | Apolipoproteins A1, Serum* | 625 | ||||||||||
Clinical Chemistry - General | Apolipoproteins B, Serum* | 625 | ||||||||||
Clinical Chemistry - General | Apolipoproteins Profile*, Serum | 1800 | ||||||||||
Anatomic pathology | Appendix | 1500 | ||||||||||
Coagulation studies (Hemostasis) | APTT, Platelet Poor Citrate Plasma | 500 | ||||||||||
Profiles | Arthritis Profile | 2550 | ||||||||||
Infectious diseases | Ascitic Fluid | 800 | ||||||||||
Cytopathology | Ascitic Fluid by Conventional method | 900 | ||||||||||
Clinical pathology | Ascitic fluid-1 | 800 | ||||||||||
Clinical pathology | Ascitic fluid-2 | 990 | ||||||||||
Clinical Chemistry - General | ASMA, Serum | 1900 | ||||||||||
Clinical Chemistry - General | ASO titre Quantitative, Serum | 600 | ||||||||||
Profiles | Atherosclerosis Risk Stratification Profile-1 | 4950 | ||||||||||
Profiles | Atherosclerosis Risk Stratification Profile-2 | 5800 | ||||||||||
Profiles | Atherosclerosis Risk Stratification Profile-3 | 6950 | ||||||||||
Profiles | Autoimmune encephalitis panel-1, CSF | 19900 | ||||||||||
Profiles | Autoimmune encephalitis panel-1, Serum | 22500 | ||||||||||
Profiles | Autoimmune Liver Disease Profile-1 | 4700 | ||||||||||
Profiles | Autoimmune Liver Disease Profile-3 | 3800 | ||||||||||
Infectious diseases | Bacteriological Examination of Air | 500 | ||||||||||
Infectious diseases | BAL, ET Secretion, other respiratory samples | 1200 | ||||||||||
Infectious diseases | BAL, ET Secretion, other respiratory samples | 1050 | ||||||||||
Infectious diseases | BAL, ET Secretion, other respiratory samples | 375 | ||||||||||
Infectious diseases | BAL, ET Secretion, other respiratory samples | 500 | ||||||||||
Profiles | Basic (Mini) | 1900 | ||||||||||
Clinical Chemistry - General | Beta 2 Glycoprotein 1, IgG Antibody, Serum * | 1100 | ||||||||||
Clinical Chemistry - General | Beta 2 Glycoprotein 1, IgM Antibody, Serum | 1100 | ||||||||||
Clinical Chemistry - General | Beta 2 Microglobulin, B2M, Serum * | 1500 | ||||||||||
Clinical Chemistry - General | Bile Acids-Total, Serum * | 1700 | ||||||||||
Clinical pathology | Bile Salt & Pigments, Urine | 75 | ||||||||||
Clinical Chemistry - General | Bilirubin Direct, Serum* | 180 | ||||||||||
Clinical Chemistry - General | Bilirubin Profile, Serum* | 280 | ||||||||||
Clinical Chemistry - General | Bilirubin Total, Serum* | 180 | ||||||||||
Anatomic pathology | Bleach | 1300 | ||||||||||
Anatomic pathology | Bleach Stain | 700 | ||||||||||
Coagulation studies (Hemostasis) | Bleeding & Clotting Time profile | 250 | ||||||||||
Infectious diseases | Blood culture 2 set, 4 bottles, aerobic by Bactec | 2800 | ||||||||||
Infectious diseases | Blood culture by Bactec | 1100 | ||||||||||
Haematology | Blood Group ABO & Rh Typing- Automated, EDTA Whole Blood. | 250 | ||||||||||
Clinical pathology | Body fluid - others | 800 | ||||||||||
Infectious diseases | Body fluids | 1050 | ||||||||||
Infectious diseases | Body fluids | 375 | ||||||||||
Infectious diseases | Body fluids eg. Pleural fluid/ Ascitic fluid/Synovial fluid/Pericardial fluid etc. | 500 | ||||||||||
Profiles | BOH Profile-Bad Obstetric History-2 | 5600 | ||||||||||
Haematology | Bone Marrow Aspiration Slides For Review* | 1300 | ||||||||||
Infectious diseases | Bone Marrow in EDTA | 1050 | ||||||||||
Profiles | Bone profile-3 | 1100 | ||||||||||
Profiles | Breast | 1920 | ||||||||||
Clinical Chemistry - General | BUN, Body Fluid* | 250 | ||||||||||
Clinical Chemistry - General | BUN, Pericardial Fluid* | 250 | ||||||||||
Clinical Chemistry - General | BUN, Serum * | 220 | ||||||||||
Clinical Chemistry - General | BUN, Spot Urine * | 250 | ||||||||||
Clinical Chemistry - General | BUN, Urine 24 H8 | 250 | ||||||||||
Cytopathology | By Conventional method | 1100 | ||||||||||
Cytopathology | By Conventional method | 750 | ||||||||||
Cytopathology | By LBC | 1100 | ||||||||||
Clinical Chemistry - General | C3 Complement , Serum * | 700 | ||||||||||
Clinical Chemistry - General | C4 Complement, Serum* | 700 | ||||||||||
Clinical Chemistry - General | CA-125, Serum | 1225 | ||||||||||
Clinical Chemistry - General | CA-15.3, Serum | 1300 | ||||||||||
Clinical Chemistry - General | CA-19.9, Serum | 1300 | ||||||||||
Clinical Chemistry - General | Calcium Ionised, Serum | 580 | ||||||||||
Clinical Chemistry - General | Calcium Profile, Serum | 550 | ||||||||||
Clinical Chemistry - General | Calcium Total, Serum * | 220 | ||||||||||
Clinical Chemistry - General | Calcium, Urine 24 H* | 250 | ||||||||||
Clinical Chemistry - General | Calcium/Creatinine Ratio, Spot Urine * | 400 | ||||||||||
Profiles | Cardiac Injury Profile-1 | 4700 | ||||||||||
Profiles | Cardiac Injury Profile-2 | 1400 | ||||||||||
Profiles | Cardiac Screen-1 | 6000 | ||||||||||
Profiles | Cardiac Screen-2 | 4300 | ||||||||||
Profiles | Cardiac Screen-3 | 1400 | ||||||||||
Clinical Chemistry - General | Cardiolipin Antibody ACL-IgG antibody, Serum* | 880 | ||||||||||
Clinical Chemistry - General | Cardiolipin Antibody ACL-IgM antibody, Serum * | 880 | ||||||||||
Haematology | CBC with ESR | 350 | ||||||||||
Haematology | CBC with ESR & MP | 475 | ||||||||||
Haematology | CBC with MP | 400 | ||||||||||
Haematology | CBC, EDTA Whole Blood | 310 | ||||||||||
Clinical Chemistry - General | CCP Antibody, Cyclic Citrullinated Peptide, Serum* | 1450 | ||||||||||
Haematology | CD 3 | 2300 | ||||||||||
Haematology | CD 4 counts | 1150 | ||||||||||
Haematology | CD 8 | 1900 | ||||||||||
Haematology | CD3/CD4/CD8 | 1900 | ||||||||||
Haematology | CD3/CD4/CD8/CD45, Whole Blood | 1900 | ||||||||||
Haematology | CD4/CD8 | 1900 | ||||||||||
Haematology | CD45 | 2300 | ||||||||||
Clinical Chemistry - General | CEA, Body Fluid * | 1000 | ||||||||||
Clinical Chemistry - General | CEA, Serum * | 780 | ||||||||||
Haematology | Cell Count, CSF or body fluid In EDTA container | 280 | ||||||||||
Infectious diseases | Central Line Tip/ Catheter Tip | 1050 | ||||||||||
Clinical Chemistry - General | Centromere Antibody, Serum | 1600 | ||||||||||
Anatomic pathology | Cervix Biopsy | 1500 | ||||||||||
Infectious diseases | Chikungunya IgM antibody by Immunochromatography, Serum* | 950 | ||||||||||
Clinical Chemistry - General | Chloride, Body Fluid * | 250 | ||||||||||
Clinical Chemistry - General | Chloride, CSF* | 250 | ||||||||||
Clinical Chemistry - General | Chloride, Serum * | 220 | ||||||||||
Clinical Chemistry - General | Chloride, Spot Urine * | 250 | ||||||||||
Clinical Chemistry - General | Chloride, Urine 24 H8* | 250 | ||||||||||
Clinical Chemistry - General | Cholesterol-Total, Body Fluid* | 250 | ||||||||||
Clinical Chemistry - General | Cholesterol-Total, Serum * | 220 | ||||||||||
Clinical Chemistry - General | Chylomicron Qualitative, Body Fluid | 500 | ||||||||||
Clinical Chemistry - General | Chylomicron Qualitative, Spot Urine | 500 | ||||||||||
Infectious diseases | Clot | 1050 | ||||||||||
Coagulation studies (Hemostasis) | Clotting Time | 130 | ||||||||||
Infectious diseases | CMV IgG & IgM antibody by CMIA, Serum | 1200 | ||||||||||
Infectious diseases | CMV IgG antibody by CMIA, Serum | 660 | ||||||||||
Infectious diseases | CMV IgM antibody by CMIA, Serum | 660 | ||||||||||
Anatomic pathology | Commando With RND / MND | 6000 | ||||||||||
Profiles | Comprehensive (Maxi) | 7750 | ||||||||||
Anatomic pathology | Congo Red Stain | 700 | ||||||||||
Haematology | Coomb's Test-Direct, EDTA Whole Blood | 650 | ||||||||||
Haematology | Coomb's Test-Indirect, Serum | 650 | ||||||||||
Clinical Chemistry - General | Cortisol, Serum * | 625 | ||||||||||
Clinical Chemistry - General | Cortisol/Creatinine ratio, Spot urine* | 1100 | ||||||||||
Clinical Chemistry - General | C-Peptide, Serum * | 1130 | ||||||||||
Clinical Chemistry - General | CPK Total, serum * | 350 | ||||||||||
Clinical Chemistry - General | CPK, MB fraction (mass), Serum* | 650 | ||||||||||
Clinical Chemistry - General | Creatinine Clearance test CCT, Serum and Urine 24 H* | 480 | ||||||||||
Clinical Chemistry - General | Creatinine Quantitative, Urine 24 H* | 290 | ||||||||||
Clinical Chemistry - General | Creatinine, Body Fluid* | 250 | ||||||||||
Clinical Chemistry - General | Creatinine, Serum* | 220 | ||||||||||
Clinical Chemistry - General | Creatinine, Spot Urine * | 250 | ||||||||||
Clinical Chemistry - General | CRP C Reactive Protein, Serum * | 500 | ||||||||||
Infectious diseases | CSF | 800 | ||||||||||
Infectious diseases | CSF | 2050 | ||||||||||
Infectious diseases | CSF (Cerebrospinal fluid) by india ink | 500 | ||||||||||
Cytopathology | CSF by Cytocentrifuge | 900 | ||||||||||
Infectious diseases | CSF(Cerebrospinal fluid) | 1050 | ||||||||||
Clinical pathology | CSF-1 | 800 | ||||||||||
Clinical pathology | CSF-2 | 1250 | ||||||||||
Cytopathology | Cytopathology-Expert opinion | 2500 | ||||||||||
Coagulation studies (Hemostasis) | D-Dimer Quantitative*, Platelet Poor Citrate Plasma | 1300 | ||||||||||
Infectious diseases | Dengue IgG antibody, Serum* | 900 | ||||||||||
Infectious diseases | Dengue IgM antibody, Serum* | 600 | ||||||||||
Infectious diseases | Dengue NS1 antigen detection, Serum* | 600 | ||||||||||
Infectious diseases | Dengue profile-1, Serum & EDTA blood | 2000 | ||||||||||
Infectious diseases | Dengue profile-2, Serum & EDTA blood | 2200 | ||||||||||
Clinical Chemistry - General | Dexamethasone High dose Suppression test For ACTH*, EDTA Plasma | 2450 | ||||||||||
Clinical Chemistry - General | Dexamethasone High dose Suppression test For Cortisol, serum * | 1300 | ||||||||||
Clinical Chemistry - General | Dexamethasone Low dose Suppression test For ACTH*, EDTA plasma | 2450 | ||||||||||
Clinical Chemistry - General | Dexamethasone Low Dose Suppression test For Cortisol, Serum | 1300 | ||||||||||
Clinical Chemistry - General | Dexamethasone Overnight Suppression test For ACTH, EDTA plasma * | 2450 | ||||||||||
Clinical Chemistry - General | Dexamethasone Overnight Suppression test For Cortisol, Serum | 1300 | ||||||||||
Clinical Chemistry - General | DHEA, Serum | 2750 | ||||||||||
Clinical Chemistry - General | DHEAS, serum * | 1070 | ||||||||||
Profiles | Diabetes Monitoring Profile-2 | 925 | ||||||||||
Profiles | Diabetes profile-Gestational | 300 | ||||||||||
Profiles | Dialysis Panel | 1900 | ||||||||||
Coagulation studies (Hemostasis) | DIC (Coagulation) Profile | 2600 | ||||||||||
Clinical Chemistry - General | DNA (Double Strand) Antibody (NcX DNA) by EIA, Serum | 1650 | ||||||||||
Cytopathology | Drain Fluid by Conventional method | 900 | ||||||||||
Clinical Chemistry - General | E2, Serum * | 650 | ||||||||||
Clinical Chemistry - General | E3, Unconjugated free estriol, Serum | 1150 | ||||||||||
Infectious diseases | Ear swab/Ear Washing in normal saline | 1050 | ||||||||||
Infectious diseases | Ear swab/Ear Washing in normal saline | 500 | ||||||||||
Clinical Chemistry - General | Electrolytes profile, Dialysis Fluid | 660 | ||||||||||
Clinical Chemistry - General | Electrolytes Profile, Serum | 525 | ||||||||||
Clinical Chemistry - General | Electrolytes Profile, Spot Urine | 600 | ||||||||||
Clinical Chemistry - General | Electrolytes Profile, Urine 24 H | 600 | ||||||||||
Anatomic pathology | Endobroncheal / Laryngeal Biopsy | 1500 | ||||||||||
Infectious diseases | Endometrium | 2050 | ||||||||||
Infectious diseases | Entamoeba histolytica detection by Wet Mount, Stool | 350 | ||||||||||
Haematology | Eosinophil Detection, Spot Urine 10ml | 330 | ||||||||||
Haematology | Eosinophil Detection, Sputum | 330 | ||||||||||
Haematology | ESR, EDTA whole blood | 100 | ||||||||||
Anatomic pathology | Extra slide set Histopathology cases | 500 | ||||||||||
Infectious diseases | Eye sample- Conjuctival Swab/Scrappings/ Vitreous fluid | 1050 | ||||||||||
Infectious diseases | Eye sample- Conjuctival Swab/Scrappings/ Vitreous fluid | 500 | ||||||||||
Anatomic pathology | Eyelid Biopsy | 1500 | ||||||||||
Anatomic pathology | Fallopian Tube | 1500 | ||||||||||
Clinical Chemistry - General | Ferritin, Serum * | 820 | ||||||||||
Profiles | Fertility Endocrine Panel, Male | 2650 | ||||||||||
Profiles | Fever Profile-1 | 1900 | ||||||||||
Profiles | Fever Profile-2 | 800 | ||||||||||
Coagulation studies (Hemostasis) | Fibrinogen level, Platelet Poor Citrated plasma | 950 | ||||||||||
Infectious diseases | Filaria Antibody detection by Immunochromatography, Serum | 1000 | ||||||||||
Infectious diseases | Filaria Antigen detection by Immunochromatography, EDTA blood | 1000 | ||||||||||
Haematology | Filaria profile, EDTA Whole Blood | 1200 | ||||||||||
Anatomic pathology | Fistulectomy / Sinus Tract | 1500 | ||||||||||
Anatomic pathology | Fite Farraco | 1300 | ||||||||||
Anatomic pathology | Fite Farraco Stain | 700 | ||||||||||
Infectious diseases | Flu panel-2, Nasopharangeal Swab | 5500 | ||||||||||
Clinical Chemistry - General | Folic Acid, Serum * | 1150 | ||||||||||
Clinical Chemistry - General | Free Beta HCG, Serum* | 1400 | ||||||||||
Clinical Chemistry - General | Free Kappa, Serum * | 2600 | ||||||||||
Clinical Chemistry - General | Free Lambda, Serum* | 2600 | ||||||||||
Clinical pathology | Fructose-qualitative, Semen | 200 | ||||||||||
Clinical Chemistry - General | FSH Follicle Stimulating Hormone, Serum * | 500 | ||||||||||
Clinical Chemistry - General | FSH-LH-Prolactin Profile, Serum* | 1450 | ||||||||||
Clinical Chemistry - General | FSH-LH-Prolactin-Testosterone Profile, Serum* | 1700 | ||||||||||
Clinical Chemistry - General | FSH-LH-Prolactin-TSH Profile, Serum * | 1600 | ||||||||||
Clinical Chemistry - General | FSH-LH-Testosterone Profile, Serum | 1350 | ||||||||||
Clinical Chemistry - General | G6PD Qualitative, EDTA whole Blood | 700 | ||||||||||
Profiles | Gall bladder | 1600 | ||||||||||
Anatomic pathology | Gall Bladder | 1500 | ||||||||||
Clinical Chemistry - General | Ganglioside IgG antibody panel, Serum | 3800 | ||||||||||
Clinical Chemistry - General | Ganglioside IgM antibody panel , Serum | 3800 | ||||||||||
Clinical Chemistry - General | GFR With Creatinine, Serum | 320 | ||||||||||
Clinical Chemistry - General | GGTP Gamma GT, Serum | 270 | ||||||||||
Anatomic pathology | GI Endoscopic Biopsy / Colonic Biopsy | 1500 | ||||||||||
Anatomic pathology | Giemsa | 1300 | ||||||||||
Anatomic pathology | Giemsa Stain | 700 | ||||||||||
Clinical Chemistry - General | Glucagon Stimulation Test For C peptide, serum | 3500 | ||||||||||
Clinical Chemistry - General | Glucose Quantitative, Spot Urine * | 125 | ||||||||||
Clinical Chemistry - General | Glucose, Fluoride Plasma* | 90 | ||||||||||
Clinical Chemistry - General | Glucose, Body Fluid * | 125 | ||||||||||
Clinical Chemistry - General | Glucose, synovial Fluid * | 125 | ||||||||||
Clinical pathology | Glucose, Urine* | 75 | ||||||||||
Anatomic pathology | Gomori Silver Methanamine (GMS) | 1300 | ||||||||||
Anatomic pathology | Gomori Silver Methanamine Stain (GMS) | 700 | ||||||||||
Infectious diseases | Gram stain of other specimen, Sputum, BAL, ET Secretion etc | 300 | ||||||||||
Clinical Chemistry - General | Growth Hormone (HGH), Serum * | 800 | ||||||||||
Clinical Chemistry - General | Growth Hormone Stimulation Test by Arginine, Serum * | 3300 | ||||||||||
Clinical Chemistry - General | Growth Hormone Stimulation Test by Clonidine, Serum * | 3300 | ||||||||||
Clinical Chemistry - General | Growth Hormone Stimulation Test by GHRH, Serum* | 3300 | ||||||||||
Clinical Chemistry - General | Growth Hormone Stimulation Test by Insulin, Serum* | 3300 | ||||||||||
Clinical Chemistry - General | Growth Hormone Stimulation Test by L Dopa, Serum* | 3300 | ||||||||||
Clinical Chemistry - General | Growth Hormone Suppression Test by Glucose, Serum* | 3300 | ||||||||||
Clinical Chemistry - General | GTT-Glucose Tolerance Test for glucose with Insulin, Serum & flouride plasma8* | 2000 | ||||||||||
Clinical Chemistry - General | GTT-Glucose Tolerance Test-2 Samples (ADA recommended), Fluoride plasma* | 190 | ||||||||||
Clinical Chemistry - General | GTT-Glucose Tolerance Test-3 Samples, Fluoride plasma* | 285 | ||||||||||
Clinical Chemistry - General | GTT-Glucose Tolerance Test-4 Samples, Fluoride plasma* | 360 | ||||||||||
Clinical Chemistry - General | GTT-Glucose Tolerance Test-5 Samples, Fluoride plasma* | 475 | ||||||||||
Clinical Chemistry - General | GTT-Glucose Tolerance Test-8 Samples, Fluoride plasma* | 760 | ||||||||||
Infectious diseases | H1N1 (Swine Flu) RNA Detection by Real Time PCR, Swab | 4500 | ||||||||||
Infectious diseases | H3 Viral marker profile by CMIA, Serum | 2000 | ||||||||||
Profiles | Haemolytic Type | 3200 | ||||||||||
Infectious diseases | Hair from root/ Scalp scrapping | 500 | ||||||||||
Infectious diseases | HAV-IgG antibody , Serum | 1100 | ||||||||||
Infectious diseases | HAV-IgM antibody, Serum | 1100 | ||||||||||
Haematology | HbA1c, EDTA Whole Blood | 590 | ||||||||||
Infectious diseases | HBeAg by CMIA , Serum | 1000 | ||||||||||
Infectious diseases | HBsAg-Quantitative, Serum | 1100 | ||||||||||
Infectious diseases | HBsAg-Screening, Serum | 500 | ||||||||||
Infectious diseases | HBV DNA Detection RT PCR, EDTA plasma | 4050 | ||||||||||
Infectious diseases | HBV DNA Viral load by RT PCR, EDTA plasma | 6000 | ||||||||||
Infectious diseases | HBV Immunity Profile, Serum | 2200 | ||||||||||
Clinical Chemistry - General | HCG as tumour marker, Serum | 800 | ||||||||||
Clinical Chemistry - General | HCG Beta Subunit for pregnancy, Serum | 700 | ||||||||||
Clinical Chemistry - General | HCG Beta Subunit, Spot Urine | 240 | ||||||||||
Clinical Chemistry - General | HCG Beta Subunit, Urine 24 H | 800 | ||||||||||
Clinical Chemistry - General | HCG Stimulation Test For FSH and LH, Serum* | 1600 | ||||||||||
Clinical Chemistry - General | HCG Stimulation Test For Testosterone, Serum* | 1000 | ||||||||||
Infectious diseases | HCV Reflex Panel, Serum | 1400 | ||||||||||
Infectious diseases | HCV RNA Detection by RT PCR, EDTA Plasma | 4050 | ||||||||||
Infectious diseases | HCV RNA Viral load by RT PCR, EDTA plasma | 7000 | ||||||||||
Infectious diseases | HCV-total antibody, Serum | 1175 | ||||||||||
Clinical Chemistry - General | HDL Cholesterol Direct, Serum * | 280 | ||||||||||
Clinical Chemistry - General | HE4 with ROMA index, Serum | 2500 | ||||||||||
Profiles | Heart failure profile, Serum | 4900 | ||||||||||
Haematology | Heinz Bodies Detection, Microscopy, EDTA Whole Blood | 220 | ||||||||||
Haematology | Hemoglobin (Hb), EDTA Whole Blood | 140 | ||||||||||
Infectious diseases | Hepatitis Profile, Comprehensive (Anti HAV IgG, IgM, Anti HCV total, Anti HEV IgM and Hepatitis B Profile) | 6650 | ||||||||||
Infectious diseases | HEV IgM Antibody by EIA, Serum | 1300 | ||||||||||
Infectious diseases | HIV-DUO, Serum | 575 | ||||||||||
Transplant immunology (HLA studies) | HLA B27 studies by Flow cytometry | 2200 | ||||||||||
Clinical Chemistry - General | HOMA Index, Serum and Flouride plasma | 1100 | ||||||||||
Clinical Chemistry - General | Homocysteine reflex B12- folate, Serum | 1700 | ||||||||||
Clinical Chemistry - General | Homocysteine, Serum | 1250 | ||||||||||
Profiles | HRT Profile* | 1225 | ||||||||||
Clinical Chemistry - General | HsCRP, Serum* | 760 | ||||||||||
Infectious diseases | HSV 1&2 IgG and IgM antibody by CLIA, Serum | 1200 | ||||||||||
Infectious diseases | HSV 1+2 IgM antibody by CLIA,Serum | 660 | ||||||||||
Infectious diseases | HSV 1+2 IgG antibody by CLIA, Serum | 660 | ||||||||||
Infectious diseases | HSV-1 IgM antibody by EIA ,Serum | 660 | ||||||||||
Infectious diseases | HSV-2 IgM antibody by EIA,Serum | 660 | ||||||||||
Clinical Chemistry - General | Hu Antibody, Serum | 4500 | ||||||||||
Infectious diseases | Hydatid Cyst Detection by wet mount, Fluid | 770 | ||||||||||
Profiles | Hypertension profile* | 1800 | ||||||||||
Clinical Chemistry - General | IgA, Serum* | 700 | ||||||||||
Allergy | IgE Total antibody* | 925 | ||||||||||
Clinical Chemistry - General | IgG Total antibody, Serum* | 700 | ||||||||||
Clinical Chemistry - General | IgM Total antibody, Serum* | 700 | ||||||||||
Clinical Chemistry - General | Immunofixation-qualitative, Serum | 5600 | ||||||||||
Clinical Chemistry - General | Immunofixation-quantitative, Serum | 7700 | ||||||||||
Clinical Chemistry - General | Immunoglobulin Profile, Serum* | 1800 | ||||||||||
Infectious diseases | India Ink Preparation, CSF | 350 | ||||||||||
Clinical Chemistry - General | Inhibin A Dimeric, Serum | 1200 | ||||||||||
Clinical Chemistry - General | Insulin Suppression test For C- peptide, Serum* | 6900 | ||||||||||
Clinical Chemistry - General | Insulin, Serum * | 850 | ||||||||||
Clinical Chemistry - General | Interleukin 6*, EDTA Plasma | 3200 | ||||||||||
Clinical Chemistry - General | Iron by Biochemical method, Serum* | 430 | ||||||||||
Clinical Chemistry - General | Iron Studies, Serum* | 750 | ||||||||||
Infectious diseases | Isospora by modified ZN Stain, Stool | 550 | ||||||||||
Clinical Chemistry - General | Jo 1 Antibody, Serum | 1550 | ||||||||||
Clinical Chemistry - General | Kappa And Lambda-Free profile, Serum* | 4500 | ||||||||||
Coagulation studies (Hemostasis) | KCT by Clotting Method, Platelet Poor Citrated plasma | 1250 | ||||||||||
Clinical Chemistry - General | Lactate, CSF * | 1050 | ||||||||||
Clinical Chemistry - General | Lactate, Fluoride Plasma* | 1050 | ||||||||||
Clinical Chemistry - General | Lactose Tolerance Test, Flouride plasma* | 600 | ||||||||||
Clinical Chemistry - General | LDH, Ascitic Fluid* | 450 | ||||||||||
Clinical Chemistry - General | LDH, Body Fluid* | 450 | ||||||||||
Clinical Chemistry - General | LDH, CSF* | 450 | ||||||||||
Clinical Chemistry - General | LDH, Peritoneal Fluid* | 450 | ||||||||||
Clinical Chemistry - General | LDH, Pleural fluid* | 450 | ||||||||||
Clinical Chemistry - General | LDH, Serum* | 360 | ||||||||||
Clinical Chemistry - General | LDL Direct Cholesterol, Serum* | 320 | ||||||||||
Clinical Chemistry - General | LH / FSH Ratio Profile , Serum* | 850 | ||||||||||
Clinical Chemistry - General | LH Luteinizing Hormone, Serum* | 500 | ||||||||||
Clinical Chemistry - General | Lipase, Body Fluid* | 660 | ||||||||||
Clinical Chemistry - General | Lipase, Serum* | 600 | ||||||||||
Clinical Chemistry - General | Lipase, Urine 24 H* | 660 | ||||||||||
Profiles | Lipid Profile-1, Serum* | 1400 | ||||||||||
Profiles | Lipid Profile-2, Serum* | 800 | ||||||||||
Profiles | Lipid Profile-3, Serum* | 450 | ||||||||||
Clinical Chemistry - General | Lithium, Serum * | 500 | ||||||||||
Clinical pathology | Liver (Hepatic) Abscess | 300 | ||||||||||
Profiles | Liver Function Test (LFT) -1* | 1475 | ||||||||||
Profiles | Liver Function Test (LFT)-2 | 1050 | ||||||||||
Profiles | Liver Function Test (LFT)-3 | 500 | ||||||||||
Veterinary | Liver Profile* | 850 | ||||||||||
Profiles | Liver-1* | 1500 | ||||||||||
Clinical Chemistry - General | LKM1 antibody , Serum | 1900 | ||||||||||
Clinical Chemistry - General | Lp(a), Lipoprotein(a), Serum* | 1050 | ||||||||||
Coagulation studies (Hemostasis) | Lupus Anticoagulants (LAC) profile, Platelet Poor Citrated plasma | 2000 | ||||||||||
Anatomic pathology | Lymph Node | 1500 | ||||||||||
Profiles | Macrocytic Anemia panel | 1900 | ||||||||||
Clinical Chemistry - General | Magnesium, Serum * | 480 | ||||||||||
Clinical Chemistry - General | Magnesium, Spot Urine * | 570 | ||||||||||
Clinical Chemistry - General | Magnesium, Urine 24 H* | 570 | ||||||||||
Infectious diseases | Malaria Parasite detection by Direct Smear examination by Microscopy, EDTA Whole Blood | 250 | ||||||||||
Infectious diseases | Malaria Profile, EDTA Whole Blood | 380 | ||||||||||
Infectious diseases | Malarial Antigen Vivax & Falciparum by Immunochromatography, EDTA Whole Blood | 650 | ||||||||||
Profiles | Menopause Comprehensive profile | 3200 | ||||||||||
Profiles | Menopause Diagnostic profile* | 1800 | ||||||||||
Profiles | Menopause Monitoring profile* | 2100 | ||||||||||
Clinical Chemistry - General | Microalbumin, Urine 24H* | 570 | ||||||||||
Clinical Chemistry - General | Microalbumin/Creatinine Ratio, Spot Urine * | 570 | ||||||||||
Clinical Chemistry - General | Mitochondrial (M2) Antibody, Serum | 1900 | ||||||||||
Coagulation studies (Hemostasis) | Mixing Studies (APTT), Platelet Poor Citrated plasma | 2500 | ||||||||||
Clinical Chemistry - General | MPO-ANCA, Serum | 1400 | ||||||||||
Anatomic pathology | Mucicarmine | 1300 | ||||||||||
Anatomic pathology | Mucicarmine Stain | 700 | ||||||||||
Anatomic pathology | Muscle Biopsy | 1800 | ||||||||||
Profiles | Myositis Profile-IgG, 11 Antigen, Serum | 9900 | ||||||||||
Infectious diseases | Nail clipping/Nail scrappings from infected area | 500 | ||||||||||
Anatomic pathology | Nasal Polyp | 1500 | ||||||||||
Infectious diseases | Neisseria sp detection by Gram stain, Urethral discharge | 300 | ||||||||||
Anatomic pathology | Nephrectomy (Non Tumorous) | 2500 | ||||||||||
Profiles | Neuronal Antibody Profile-1 | 8500 | ||||||||||
Cytopathology | Nipple Discharge by Conventional method | 900 | ||||||||||
Clinical Chemistry - General | NMO (Aquaporin 4)-IgG antibody , CSF | 4500 | ||||||||||
Clinical Chemistry - General | NMO (Aquaporin 4)-IgG antibody, Serum | 4500 | ||||||||||
Clinical Chemistry - General | NMO antibody profile, CSF and Serum | 7500 | ||||||||||
Clinical Chemistry - General | NMO with MOG Antibody Profile for serum | 6500 | ||||||||||
Clinical Chemistry - General | NMO with MOG Antibody Profile, CSF | 6600 | ||||||||||
Infectious diseases | Nocardia Detection by modified ZN Stain, Sputum | 550 | ||||||||||
Infectious diseases | Nocardia Detection by modified ZN Stain, Tissue | 550 | ||||||||||
Clinical Chemistry - General | NT-Pro BNP, Serum* | 2700 | ||||||||||
Infectious diseases | Nugent's score by Gram stain, Vaginal discharge | 400 | ||||||||||
Profiles | Nutritional | 3750 | ||||||||||
Clinical pathology | Occult blood, Stool | 150 | ||||||||||
Clinical pathology | Occult blood, Urine | 75 | ||||||||||
Haematology | Osmotic RBC Fragility Test, Sodium Heparin Whole Blood | 850 | ||||||||||
Infectious diseases | OT microbioligical surveillance panel (5 Swab) | 2250 | ||||||||||
Infectious diseases | OT microbioligical surveillance per swab | 500 | ||||||||||
Cytopathology | Other Fluids by Conventional method | 900 | ||||||||||
Infectious diseases | Other Sample Type | 2050 | ||||||||||
Infectious diseases | Other samples | 2200 | ||||||||||
Infectious diseases | Others sample type | 1050 | ||||||||||
Infectious diseases | Others samples- Vaginal swab/ Vaginal discharge/Throat swab/Semen | 500 | ||||||||||
Profiles | Ovarian, Comprehensive* | 2250 | ||||||||||
Profiles | Pacer-26 * | 2300 | ||||||||||
Profiles | Pancreatic (Acute) Profile* | 1600 | ||||||||||
Clinical Chemistry - General | PAPPa, Serum* | 1400 | ||||||||||
Profiles | Parathyroid Panel* | 2850 | ||||||||||
Anatomic pathology | PAS with and / or Without Diastase | 1300 | ||||||||||
Anatomic pathology | PAS With and / or Without Diastase Stain | 700 | ||||||||||
Profiles | PCOS profile-1* | 3300 | ||||||||||
Infectious diseases | Pedicardial Fluid | 800 | ||||||||||
Clinical pathology | Pericardial Fluid | 800 | ||||||||||
Cytopathology | Pericardial Fluid by Conventional method | 900 | ||||||||||
Haematology | Peripheral Smear Examination By Pathologist, EDTA Whole Blood | 300 | ||||||||||
Infectious diseases | Peritoneal Fluid | 800 | ||||||||||
Clinical pathology | Peritoneal Fluid | 800 | ||||||||||
Cytopathology | Peritoneal washings by Conventional method | 900 | ||||||||||
Clinical pathology | pH, Stool | 100 | ||||||||||
Clinical pathology | pH, Urine | 75 | ||||||||||
Profiles | Phospholipid Syndrome Profile | 4100 | ||||||||||
Clinical Chemistry - General | Phosphorus-Inorganic, Serum* | 220 | ||||||||||
Clinical Chemistry - General | Phosphorus-Inorganic, Spot Urine* | 300 | ||||||||||
Clinical Chemistry - General | Phosphorus-Inorganic, Urine 24 H* | 300 | ||||||||||
Profiles | Pituitary hormones Profile* | 3750 | ||||||||||
Haematology | Platelet Count, EDTA Whole Blood | 220 | ||||||||||
Cytopathology | Pleural Fluid by Conventional method | 900 | ||||||||||
Clinical pathology | Pleural Fluid-1 | 800 | ||||||||||
Clinical pathology | Pleural fluid-2 | 1390 | ||||||||||
Infectious diseases | PleuralFluid | 800 | ||||||||||
Clinical Chemistry - General | PNMA2 (MA2 / TA) Antibody, Serum | 4800 | ||||||||||
Clinical Chemistry - General | Potassium, Body Fluid* | 270 | ||||||||||
Clinical Chemistry - General | Potassium, Serum* | 220 | ||||||||||
Clinical Chemistry - General | Potassium, Spot Urine* | 270 | ||||||||||
Clinical Chemistry - General | Potassium, Urine 24 H* | 275 | ||||||||||
Clinical Chemistry - General | PR3 ANCA, Serum | 1450 | ||||||||||
Coagulation studies (Hemostasis) | Pre screening for Bleeding Disorders | 4200 | ||||||||||
Maternal Screening | Pregascreen Dual* | 3500 | ||||||||||
Maternal Screening | Pregascreen Quadruple | 4000 | ||||||||||
Clinical pathology | Pregnancy test, Urine | 150 | ||||||||||
Profiles | Pre-Operative Profile-1* | 2100 | ||||||||||
Profiles | Pre-Operative Profile-2* | 1280 | ||||||||||
Clinical Chemistry - General | Procalcitonin (PCT), Serum* | 2350 | ||||||||||
Clinical Chemistry - General | Progesterone (P4), Serum * | 600 | ||||||||||
Clinical Chemistry - General | Prolactin Tripooled, Serum* | 600 | ||||||||||
Clinical Chemistry - General | Prolactin, Serum * | 550 | ||||||||||
Clinical pathology | Prostatic Fluid | 800 | ||||||||||
Clinical Chemistry - General | Protein Electrophoresis Reflex immunofixation (Qualitative), Serum | 2300 | ||||||||||
Clinical Chemistry - General | Protein Electrophoresis SPE, Serum | 770 | ||||||||||
Clinical Chemistry - General | Proteins, Ascitic Fluid* | 275 | ||||||||||
Clinical Chemistry - General | Proteins, Body Fluid * | 275 | ||||||||||
Clinical Chemistry - General | Proteins, CSF * | 275 | ||||||||||
Clinical Chemistry - General | Proteins, Pericardial Fluid* | 275 | ||||||||||
Clinical Chemistry - General | Proteins, Peritoneal Fluid * | 275 | ||||||||||
Clinical Chemistry - General | Proteins, Pleural Fluid * | 275 | ||||||||||
Clinical Chemistry - General | Proteins, Serum* | 220 | ||||||||||
Clinical Chemistry - General | Proteins, Synovial fluid* | 275 | ||||||||||
Clinical Chemistry - General | Proteins, Urine 24 H* | 275 | ||||||||||
Clinical Chemistry - General | Proteins/Creatinine Ratio, Spot Urine * | 550 | ||||||||||
Coagulation studies (Hemostasis) | Prothrombin Time (PT), Citrate plasma | 380 | ||||||||||
Anatomic pathology | Prussian Blue | 1300 | ||||||||||
Anatomic pathology | Prussian Blue Stain | 700 | ||||||||||
Clinical Chemistry - General | PSA Reflex Free PSA, Serum | 1050 | ||||||||||
Clinical Chemistry - General | PSA with Free PSA ratio, Serum | 1500 | ||||||||||
Clinical Chemistry - General | PSA-Free, Serum* | 900 | ||||||||||
Clinical Chemistry - General | PSA-total, Serum* | 800 | ||||||||||
Clinical Chemistry - General | PTH-Intact Molecule, EDTA plasma* | 1600 | ||||||||||
Infectious diseases | Pus | 800 | ||||||||||
Infectious diseases | Pus / Abscess / Aspirate | 2050 | ||||||||||
Infectious diseases | Pus swab/Pus/Abscessus/ Wound swab | 1050 | ||||||||||
Infectious diseases | Pus swab/Pus/Abscessus/ Wound swab | 500 | ||||||||||
Infectious diseases | Pus, abscess and aspirates | 375 | ||||||||||
Clinical Chemistry - General | RA test, Serum * | 600 | ||||||||||
Clinical Chemistry - General | RA test, Synovial Fluid* | 700 | ||||||||||
Clinical pathology | Reducing Substances, Stool | 200 | ||||||||||
Clinical pathology | Reducing Substances, Urine | 100 | ||||||||||
Profiles | Renal (Kidney) Function Tests- 1 RFT Maxi | 1900 | ||||||||||
Profiles | Renal (Kidney) Function Tests- 2 RFT Mini | 1000 | ||||||||||
Anatomic pathology | Reticulin | 1300 | ||||||||||
Anatomic pathology | Reticulin Stain | 700 | ||||||||||
Haematology | Reticulocyte count profile, EDTA Whole Blood | 400 | ||||||||||
Haematology | Rh Antibody Titre by Tube Method, Serum | 900 | ||||||||||
Profiles | Rheumatic Fever Panel | 1650 | ||||||||||
Profiles | Rheumatoid Arthritis Panel-1* | 2550 | ||||||||||
Profiles | Rheumatoid Arthritis Panel-2 | 5100 | ||||||||||
Profiles | Rheumatoid Arthritis Panel-3 | 7750 | ||||||||||
Profiles | Rheumatology Profile | 5900 | ||||||||||
Clinical Chemistry - General | Ri Antibody, Serum | 4500 | ||||||||||
Clinical Chemistry - General | Ribosome antibodies, serum | 7000 | ||||||||||
Clinical Chemistry - General | RNP-Sm Antibody, Serum | 1750 | ||||||||||
Infectious diseases | Rubella Virus IgG and IgM antibody, Serum | 1200 | ||||||||||
Infectious diseases | Rubella Virus IgG antibody by CMIA, Serum | 660 | ||||||||||
Infectious diseases | Rubella Virus IgM antibody by CMIA, Serum | 660 | ||||||||||
Coagulation studies (Hemostasis) | RVVT-Russell Viper Venom Time, Platelet Poor Citrated Plasma | 1000 | ||||||||||
Clinical Chemistry - General | SAAG-Serum Ascites Albumin Gradient, Serum and Ascitic Fluid* | 500 | ||||||||||
Infectious diseases | SARS CoV2 Antigen Reflex to SARS CoV2 real time RT PCR (COVID 19 Antigen reflex test)* | 2200 | ||||||||||
Infectious diseases | SARS CoV2 Antigen test(COVID 19 antigen test) | 600 | ||||||||||
Infectious diseases | SARS-CoV-2 (COVID 19) Detection (Qualitative) by Real Time rt PCR* | 2500 | ||||||||||
Clinical Chemistry - General | Scl-70 Antibody, Serum | 1650 | ||||||||||
Profiles | Scleroderma Panel | 5250 | ||||||||||
Anatomic pathology | Sebaceous cyst | 1500 | ||||||||||
Anatomic pathology | Second opinion | 1200 | ||||||||||
Veterinary | Second opinion service, Sldies and blocks | 2500 | ||||||||||
Veterinary | Second opinion services, Slides | 1000 | ||||||||||
Clinical pathology | Semen | 500 | ||||||||||
Infectious diseases | Semen | 1050 | ||||||||||
Infectious diseases | Serum | 800 | ||||||||||
Clinical Chemistry - General | SGOT, Serum * | 220 | ||||||||||
Clinical Chemistry - General | SGPT, Serum* | 220 | ||||||||||
Haematology | Sickling Test by Solubility method , EDTA Whole Blood | 300 | ||||||||||
Profiles | Sjogren's Syndrome Profile | 2500 | ||||||||||
Anatomic pathology | Skin Biopsy | 1500 | ||||||||||
Infectious diseases | Skin scrappings from infected area | 500 | ||||||||||
Profiles | SLE profile | 4800 | ||||||||||
Clinical Chemistry - General | Sm Smith Antibody, serum | 1550 | ||||||||||
Profiles | SMA 12+2 | 1550 | ||||||||||
Clinical Chemistry - General | Sodium , Body Fluid* | 275 | ||||||||||
Clinical Chemistry - General | Sodium, Serum * | 220 | ||||||||||
Clinical Chemistry - General | Sodium, spot Urine * | 275 | ||||||||||
Clinical Chemistry - General | Sodium, Urine 24 H* | 275 | ||||||||||
Clinical pathology | Specific gravity, Urine | 75 | ||||||||||
Anatomic pathology | Spleen | 2000 | ||||||||||
Clinical pathology | Sputum | 800 | ||||||||||
Infectious diseases | Sputum / BAL | 2050 | ||||||||||
Infectious diseases | Sputum / BAL | 2200 | ||||||||||
Infectious diseases | Sputum- 1 sample | 375 | ||||||||||
Cytopathology | Sputum by Conventional method | 900 | ||||||||||
Infectious diseases | Sputum/ induced sputum | 500 | ||||||||||
Infectious diseases | Sputum/ induced sputum | 1050 | ||||||||||
Infectious diseases | Sputum-3 samples | 800 | ||||||||||
Clinical Chemistry - General | SSA-Antibody (Ro Antibody ), Serum | 1650 | ||||||||||
Clinical Chemistry - General | SSB-Antibody (La Antibody) Serum * | 1650 | ||||||||||
Clinical pathology | Stool | 250 | ||||||||||
Infectious diseases | Stool in sterile container | 1050 | ||||||||||
Anatomic pathology | Synovial Biopsy | 1500 | ||||||||||
Infectious diseases | synovial fluid | 800 | ||||||||||
Clinical pathology | Synovial Fluid | 800 | ||||||||||
Cytopathology | Synovial Fluid by Conventional method | 900 | ||||||||||
Clinical Chemistry - General | T3 Free, Serum* | 275 | ||||||||||
Clinical Chemistry - General | T3 Total, Serum* | 200 | ||||||||||
Clinical Chemistry - General | T4 Free, Serum* | 275 | ||||||||||
Clinical Chemistry - General | T4 Total, Serum* | 200 | ||||||||||
Drugs - Therapeutic & drugs of abuse | Tacrolimus By CMIA, EDTA Whole Blood | 3900 | ||||||||||
Profiles | Testicular | 1300 | ||||||||||
Anatomic pathology | Testicular biopsy | 1500 | ||||||||||
Clinical Chemistry - General | Testosterone Free, Serum | 1650 | ||||||||||
Clinical Chemistry - General | Testosterone Total*, Serum | 700 | ||||||||||
Haematology | Thalassemia Studies profile, EDTA Whole Blood and Serum | 1500 | ||||||||||
Infectious diseases | Throat Swab | 1050 | ||||||||||
Infectious diseases | Throat Swab For C.diphtheriae | 1050 | ||||||||||
Clinical Chemistry - General | Thyroglobulin Antibody, Serum | 1200 | ||||||||||
Clinical Chemistry - General | Thyroid Antibodies profile, Serum | 1990 | ||||||||||
Clinical Chemistry - General | Thyroid Comprehensive Profile-1, Serum* | 2700 | ||||||||||
Clinical Chemistry - General | Thyroid Comprehensive Profile-2, Serum * | 1600 | ||||||||||
Clinical Chemistry - General | Thyroid Panel 1 - Total, Serum * | 550 | ||||||||||
Clinical Chemistry - General | Thyroid Panel 2, Free, Serum* | 750 | ||||||||||
Clinical Chemistry - General | Thyroid Panel 3 Reflex, Serum* | 400 | ||||||||||
Clinical Chemistry - General | Thyroid Panel 4, Serum* | 440 | ||||||||||
Anatomic pathology | Thyroidectomy | 2900 | ||||||||||
Clinical Chemistry - General | TIBC, Serum * | 450 | ||||||||||
Infectious diseases | Tissue / Biopsy / Lymph nodes | 2050 | ||||||||||
Anatomic pathology | Tissue processing | 500 | ||||||||||
Infectious diseases | Tissue/ Biopsy/ Lymph node etc | 375 | ||||||||||
Infectious diseases | Tissue/ Biopsy/ Lymph node etc | 500 | ||||||||||
Infectious diseases | Tissue/ Biopsy/ Lymph node etc | 1050 | ||||||||||
Profiles | TORCH-10 | 3000 | ||||||||||
Profiles | TORCH-4 IgG | 1450 | ||||||||||
Profiles | TORCH-4 IgM | 1450 | ||||||||||
Profiles | TORCH-5 IgG | 1600 | ||||||||||
Profiles | TORCH-5 IgM | 1600 | ||||||||||
Profiles | TORCH-8 | 2600 | ||||||||||
Infectious diseases | Toxoplasma-IgG and IgM antibodies, Serum | 1300 | ||||||||||
Infectious diseases | Toxoplasma-IgG Antibody - Serum | 660 | ||||||||||
Infectious diseases | Toxoplasma-IgM Antibody , Serum | 660 | ||||||||||
Clinical Chemistry - General | TPO (Thyroid Peroxidase) Antibody, Serum | 1200 | ||||||||||
Clinical Chemistry - General | TRH stimulation test For Prolactin, Serum* | 1350 | ||||||||||
Clinical Chemistry - General | TRH stimulation test For TSH, Serum | 1100 | ||||||||||
Clinical Chemistry - General | Triglycerides, Body Fluid * | 375 | ||||||||||
Clinical Chemistry - General | Triglycerides, Serum * | 280 | ||||||||||
Clinical Chemistry - General | Triglycerides, Spot Urine * | 375 | ||||||||||
Maternal Screening | Triple marker test | 2800 | ||||||||||
Clinical Chemistry - General | Troponin I- High sensitive, Serum * | 1650 | ||||||||||
Clinical Chemistry - General | TSH-Ultrasensitive, Serum * | 350 | ||||||||||
Clinical Chemistry - General | tTG Antibody-IgA, Serum* | 1150 | ||||||||||
Infectious diseases | Typhi Dot IgM by Immunochromatography Rapid test, Serum | 600 | ||||||||||
Profiles | Typhoid Profile | 1920 | ||||||||||
Haematology | Tzanck Smear, Smears | 400 | ||||||||||
Clinical Chemistry - General | U1-SnRNP (68 KDa) antibody, Serum | 1650 | ||||||||||
Clinical Chemistry - General | UIBC, Serum* | 280 | ||||||||||
Anatomic pathology | Unspecified specimen-Large | 2900 | ||||||||||
Anatomic pathology | Unspecified specimen-Large & Complex | 7500 | ||||||||||
Anatomic pathology | Unspecified specimen- Medium | 1500 | ||||||||||
Anatomic pathology | Unspecified specimen-Small | 1100 | ||||||||||
Clinical Chemistry - General | Urea Clearance Test, Serum and Urine 24 H | 550 | ||||||||||
Clinical Chemistry - General | Urea, Serum * | 220 | ||||||||||
Clinical Chemistry - General | Urea, Urine 24H* | 275 | ||||||||||
Infectious diseases | Urethral Discharge | 1050 | ||||||||||
Clinical Chemistry - General | Uric Acid, Serum* | 220 | ||||||||||
Clinical Chemistry - General | Uric Acid, Spot Urine * | 275 | ||||||||||
Clinical Chemistry - General | Uric Acid, Urine 24 H* | 275 | ||||||||||
Clinical pathology | Urine | 160 | ||||||||||
Infectious diseases | Urine | 1050 | ||||||||||
Infectious diseases | Urine - 1 sample | 375 | ||||||||||
Infectious diseases | Urine in sterile container | 500 | ||||||||||
Infectious diseases | Urine-3 samples | 800 | ||||||||||
Clinical Chemistry - General | Urobilinogen Qualitative, Spot Urine | 100 | ||||||||||
Anatomic pathology | Uterus With/Without Adnexae | 2000 | ||||||||||
Infectious diseases | Vaginal swab/ Vaginal discharge Sample includes group B Streptococci | 1050 | ||||||||||
Drugs - Therapeutic & drugs of abuse | Valproic Acid by petinia, Serum | 875 | ||||||||||
Profiles | Vasculitis profile, Serum | 4000 | ||||||||||
Infectious diseases | VDRL (RPR) by Flocculation, Serum | 290 | ||||||||||
Infectious diseases | Vibrio Cholerae detection by hanging drop, Stool | 400 | ||||||||||
Clinical Chemistry - General | Vitamin B12 by CMIA, Serum* | 1150 | ||||||||||
Clinical Chemistry - General | Vitamin D Total-25 Hydroxy (VIT D PLUS+)*, EDTA plasma | 1650 | ||||||||||
Clinical Chemistry - General | Vitamin D Total-25 Hydroxy, Serum * | 1650 | ||||||||||
Clinical Chemistry - General | Vitamin D-1,25-Dihydroxy by CLIA, Serum | 3400 | ||||||||||
Non-biological sample tests | Water Culture for coliforms for potability | 600 | ||||||||||
Haematology | WBC:Total & Differential Counts, Body Fluids | 250 | ||||||||||
Haematology | WBC:Total & Differential Counts, EDTA Whole Blood | 200 | ||||||||||
Haematology | WBC-Total Counts, Body Fluids | 200 | ||||||||||
Anatomic pathology | Werthiems Hysterectomy | 7500 | ||||||||||
Anatomic pathology | Whipples Resection | 7500 | ||||||||||
Infectious diseases | Widal Test by tube Agglutination, Serum | 500 | ||||||||||
Profiles | Workup Profile | 2100 |